Related Experiment Video
Updated: Aug 5, 2026

High-throughput Identification of Bacteria Repellent Polymers for Medical Devices
Published on: November 5, 2016
Synthetic polypeptide adjuvant-antibiotic combination eradicates polymicrobial assemblies, dormant bacteria and
Swagatam Barman1, Md Waliullah Hossain2, Aiswarya Chandrasseril Bansidhar2
1Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina 29208, United States; Department of Environmental Health Sciences, University of South Carolina, Columbia, South Carolina, 29208, United States.
Abstract:
In this work, we explore the potency of poly(D-peptide) (D-PP) in combination with diverse classes of antibiotics to address multidrug-resistant (MDR) Gram-negative superbugs, including their mature biofilms, polymicrobial assemblies, and dormant subpopulations, which are among complex challenging targets. The polypeptide adjuvant displayed significant antibiotic potentiation, resulting in a moderate to rapid bactericidal activity against the Gram-negative pathogens in their planktonic stage. The adjuvant and its combination restored susceptibility in dormant bacterial subpopulations. In polymicrobial settings, these combinations were able to reduce both Gram-negative and Gram-positive bacterial species, unlike individual antibiotic exposure. Importantly, one of the lead combinations (D-PP-rifampicin) resulted in moderate biofilm eradication of P. aeruginosa. Transcriptomic analysis demonstrated the differentially expressed genes (DEGs) involved in membrane integrity, stress response, and transport systems. Together with our previous mechanistic findings, this further confirmed that bacterial membrane perturbation is caused by the adjuvant. Such perturbation facilitated antibiotic accumulation within microbial cells. Furthermore, polypeptide reduces the bacterial resistance development towards doxycycline and rifampicin, unlike polymyxin B. Taken together, these findings exhibit that membrane-active polypeptide adjuvants can enhance antibiotic efficacy across diverse bacterial states and environments, providing a promising strategy to combat persistent and multidrug-resistant infections.
Insights
Poly(D-peptide) (D-PP) adjuvants enhance antibiotic effectiveness against multidrug-resistant (MDR) Gram-negative bacteria. These combinations combat biofilms, dormant cells, and reduce resistance development, offering a new strategy for persistent infections.
Area of Science:
- Microbiology
- Drug Discovery
- Biotechnology
Background:
- Multidrug-resistant (MDR) Gram-negative bacteria pose a significant global health threat.
- Treating complex infections involving biofilms, dormant cells, and polymicrobial communities remains challenging.
- Novel strategies are needed to overcome existing antibiotic limitations.
Purpose of the Study:
- To evaluate the efficacy of poly(D-peptide) (D-PP) as an adjuvant in combination with antibiotics against MDR Gram-negative bacteria.
- To investigate the adjuvant's impact on bacterial biofilms, dormant subpopulations, and polymicrobial infections.
- To elucidate the mechanisms underlying D-PP's synergistic effects and its role in preventing resistance.
Main Methods:
- Combination therapy testing of D-PP with various antibiotic classes against planktonic and sessile bacteria.
- Assessment of D-PP combinations against dormant bacterial subpopulations and polymicrobial cultures.
- Biofilm eradication assays and transcriptomic analysis to identify differentially expressed genes (DEGs).
Main Results:
- D-PP significantly potentiated antibiotic activity, leading to rapid bactericidal effects against planktonic Gram-negative pathogens.
- Combinations restored antibiotic susceptibility in dormant bacterial subpopulations and reduced both Gram-negative and Gram-positive species in polymicrobial settings.
- D-PP-rifampicin demonstrated moderate biofilm eradication of P. aeruginosa, and transcriptomic data indicated membrane perturbation as a key mechanism.
Conclusions:
- Membrane-active polypeptide adjuvants like D-PP can enhance antibiotic efficacy against diverse bacterial states and environments.
- These combinations offer a promising strategy to combat persistent and multidrug-resistant infections.
- D-PP reduces bacterial resistance development to certain antibiotics, unlike polymyxin B.
Related Concept Videos
Biological Methods for Microbial Control
Biofilms
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Gram-positive Cell Wall Synthesis
Microorganisms in Medicine and Therapeutics

